Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $5.86 $7.43 Friday, 10th May 2024 REPL stock ended at $6.41. This is 4.75% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 8.93% from a day low at $6.38 to a day high of $6.95.
90 days $5.86 $9.20
52 weeks $5.86 $24.81

Historical Replimune Group Inc. prices

Date Open High Low Close Volume
May 10, 2024 $6.76 $6.95 $6.38 $6.41 316 883
May 09, 2024 $6.65 $6.79 $6.51 $6.73 453 554
May 08, 2024 $6.78 $6.83 $6.57 $6.68 526 785
May 07, 2024 $7.04 $7.21 $6.83 $6.88 326 919
May 06, 2024 $7.22 $7.24 $6.93 $7.01 400 633
May 03, 2024 $6.80 $7.08 $6.71 $6.95 618 418
May 02, 2024 $6.54 $6.66 $6.37 $6.56 440 820
May 01, 2024 $6.36 $6.76 $6.23 $6.48 841 710
Apr 30, 2024 $6.49 $6.61 $6.35 $6.35 435 737
Apr 29, 2024 $6.46 $6.78 $6.35 $6.58 454 982
Apr 26, 2024 $6.22 $6.58 $6.06 $6.42 576 569
Apr 25, 2024 $6.18 $6.33 $5.86 $6.15 756 035
Apr 24, 2024 $6.41 $6.66 $6.20 $6.33 631 809
Apr 23, 2024 $6.47 $6.77 $6.39 $6.42 1 136 327
Apr 22, 2024 $6.56 $6.66 $6.22 $6.42 502 632
Apr 19, 2024 $6.90 $7.07 $6.33 $6.45 866 605
Apr 18, 2024 $7.20 $7.43 $6.95 $6.97 1 103 034
Apr 17, 2024 $7.19 $7.33 $7.14 $7.21 1 087 608
Apr 16, 2024 $7.01 $7.25 $6.92 $7.15 670 627
Apr 15, 2024 $7.14 $7.26 $7.07 $7.12 625 509
Apr 12, 2024 $7.17 $7.29 $6.97 $7.14 893 234
Apr 11, 2024 $7.07 $7.31 $6.82 $7.19 680 061
Apr 10, 2024 $7.01 $7.03 $6.72 $6.96 913 278
Apr 09, 2024 $7.09 $7.34 $7.09 $7.28 673 706
Apr 08, 2024 $7.43 $7.45 $7.12 $7.12 550 934
Click to get the best stock tips daily for free!

About Replimune Group Inc.

Replimune Group. Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Pha... REPL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT